Decoding Key Probes for the Diagnosis and Treatment of Multiple Myeloma
FITC-Labeled Syndecan-1/CD138 His Tag protein is an advanced fluorescently labeled tool protein that plays a significant role in the study of diseases such as multiple myeloma.
- Recent Advances
- Product Information
FITC-Labeled Syndecan-1/CD138 His Tag protein is an advanced fluorescently labeled tool protein that plays a crucial role in research on diseases such as multiple myeloma. This article will comprehensively analyze the molecular characteristics and technical advantages of this protein, delve into its important applications in the diagnosis of multiple myeloma, treatment monitoring, and research on epithelial-derived tumors, and reveal its unique value in preclinical research.
1. Molecular Structure Analysis: What is FITC-Labeled Syndecan-1/CD138 His Tag Protein?
This is a recombinant protein probe that integrates specificity, sensitivity, and practicality, consisting of three meticulously designed core components:
Syndecan-1/CD138 Target Domain
- Biological Nature: Transmembrane heparan sulfate proteoglycan, an important cell surface receptor
- Core Functions:
- Key regulator of cell adhesion, migration, and proliferation
- Bridge molecule for cell-extracellular matrix interactions
- Tissue Distribution:
- Normal tissues: Mainly expressed in epithelial cells and plasma cells
- Pathological states: Abnormally overexpressed in specific tumors
His Tag Purification Marker
- Structural Feature: 6× histidine short peptide tag
- Technical Advantages:
- High-purity preparation: Achieves single-step efficient purification via nickel column affinity chromatography
- Stability assurance: Ensures structural integrity and biological activity of the protein
- Detection flexibility: Supports signal amplification detection using anti-His antibodies
FITC Fluorescent Reporter Group
- Optical Properties: Classic green fluorescent dye (excitation peak at 495nm, emission peak at 519nm)
- Application Advantages:
- Broad compatibility: Suitable for most flow cytometers and fluorescence microscopes
- Cost-effectiveness: Mature technology with low detection costs
- Operational simplicity: Ideal for high-throughput screening and routine detection
Comprehensive definition: This is a research tool constructed through genetic engineering, perfectly combining disease-related targets (Syndecan-1/CD138), efficient purification tags (His Tag), and sensitive detection groups (FITC).
2. Technical Advantages and Application Scenarios
Core Technical Advantages
- Target specificity: Maintains the natural conformation and binding activity of Syndecan-1
- Detection sensitivity: FITC provides stable and reliable fluorescent signals
- Operational simplicity: Suitable for laboratories of various scales
Main Application Directions
Flow Cytometry Analysis
- Quantification of CD138 expression on plasma cell surfaces
- Tumor cell sorting and identification
- Monitoring of cell differentiation states
Immunofluorescence Staining
- Localization analysis of Syndecan-1 in tissue sections
- Research on cell membrane protein distribution
- Co-localization studies
Functional Studies
- Ligand-receptor interaction analysis
- Signal pathway activation research
- Exploration of cell adhesion mechanisms
3. Disease Association: Multiple Myeloma and Other Disease Research
1. Multiple Myeloma (Core Application Area)
Diagnostic Value
- Gold standard marker: CD138 is a definitive marker for plasma cells and multiple myeloma cells
- Minimal residual disease monitoring: Detection of residual malignant plasma cells post-treatment
- Disease classification: Assists in molecular typing and prognosis judgment of multiple myeloma
Therapeutic Applications
Targeted therapy development:
- Antibody-drug conjugate target validation
- CAR-T cell therapy target screening
Treatment response evaluation:
- Monitoring changes in CD138 expression before and after treatment
- Assessing treatment efficacy and drug resistance
Mechanism Research
- Tumor microenvironment: Study the role of Syndecan-1 in the bone marrow microenvironment
- Disease progression: Explore its mechanisms in the development of myeloma
2. Other Plasma Cell Diseases
- Monoclonal gammopathy of undetermined significance
- Waldenström macroglobulinemia
- Plasma cell leukemia
3. Epithelial-Derived Tumors
Breast cancer:
- Prognostic assessment indicator
- Metastasis potential prediction
Head and neck tumors:
- Diagnostic and prognostic markers
- Exploration of therapeutic targets
Hepatocellular carcinoma:
- Disease progression monitoring
- Prognostic evaluation
4. Other Disease Areas
Fibrotic diseases:
- Pulmonary fibrosis
- Liver fibrosis
Wound healing:
- Monitoring of epithelial repair processes
- Tissue regeneration research
4. Research Progress and Future Prospects
Current Research Hotspots
Precision Medicine for Multiple Myeloma
- CD138-based personalized treatment strategies
- Development of novel targeted drugs
Tumor Microenvironment Research
- Role of Syndecan-1 in tumor-stroma interactions
- Microenvironment regulation mechanisms
Diagnostic Technology Innovation
- Development of new liquid biopsy methods
- Establishment of high-sensitivity detection platforms
Technology Development Trends
Multi-Omics Integration
- Integration with single-cell sequencing technology
- Proteomics correlation analysis
Clinical Translation Applications
- Development of diagnostic kits
- Establishment of companion diagnostic standards
Treatment Monitoring Innovation
- New methods for real-time efficacy evaluation
- Guidance for personalized treatment plans
Summary
The value of FITC-Labeled Syndecan-1/CD138 His Tag protein is mainly reflected in:
Diagnostic Value:
Gold standard tool for the diagnosis and classification of multiple myeloma
Research Value:
Key probe for plasma cell biology and tumor microenvironment research
Therapeutic Value:
Important platform for targeted therapy development and efficacy evaluation
Prognostic Value:
Reliable indicator for disease progression monitoring and prognosis judgment
With the advancement of precision medicine, this protein tool will continue to play a significant role in the research of hematological tumors and epithelial-derived tumors, providing new solutions for disease diagnosis and treatment.
This article is reviewed and published by the technical expert team of UA
Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.
Purchase recombinant protein, choose Nanjing UA-Bio
UA protein focuses on providing various protein reagents, raw materials, and services required for drug research and development, cell therapy, gene therapy, and basic scientific research, including drug target proteins, immune checkpoint proteins, cytokines, tool enzymes, customized protein expression, and full-length transmembrane protein development. Youai is committed to providing customers with high-quality products and professional services, and building a High-tech Biological Enterprise with International Competitiveness.
Business license (three certificates in one) 